WFDC2 and cancer: TK1 has been proved to be a new biomarker in several cancers, including hepatocellular carcinoma17, prostate cancer18, melanoma19, and breast cancer20 et al. In addition, TK1 combined with HE4 and CA125 showed a better diagnostic performance in ovarian cancer21,22.